Totient preview
Totient favicon

Totient Review

April 2026

$1M
Revenue
6
Employees
20%
Growth
Estimated Revenue
$1M
Total Employees
6
Employee Growth
20%
Industry
Biotech
About

Absci is a clinical-stage biopharmaceutical company advancing innovative therapeutics with generative AI.

Global Rank
N/A

What is Totient's Revenue?

Totient's estimated revenue is $1M.

What does Totient do?

Absci is a clinical-stage biopharmaceutical company advancing innovative therapeutics with generative AI.

CompanyRevenueEmployeesGrowthFunding
UltivueUltivue
$12.7M82-45.1%$107.3M
Ohana BiosciencesOhana Biosciences
$0.2M1-50.0%N/A
MatterworksMatterworks
$6.2M4022.2%N/A
Tango TherapeuticsTango Therapeutics
$42.2M2184.1%$165M
GelesisGelesis
$14.6M94-36.9%$312.8M
BOSLabBOSLab
$0.3M2-60.0%N/A
Akebia TherapeuticsAkebia Therapeutics
$235.0M366-4.8%$340.9M
Elucidata CorporationElucidata Corporation
$56.0M289-7.4%$7.6M
TRIANA BiomedicinesTRIANA Biomedicines
$4.7M6135.1%N/A
GensaicGensaic
$2.0M1310.0%N/A
☁️Cloud & Hosting1
📝CMS1
🎯CSS Frameworks2
🔧Customer Support1
🔧Fonts1
🎨JavaScript Libraries3
🔧Programming Languages1
🔒Security2
🎯UI Libraries1
🔧Web Standards1
Tracking & Analytics16
L
LinkedIn Insight Tag
G
Google Analytics
G
Google Tag Manager
H
Hotjar
H
Hotjar
T
Twitter Pixel
G
Google Tag Manager
H
Hotjar
G
Google Static
T
Twitter Ads
L
LinkedIn Insight Tag
T
Twitter/X
G
Google Analytics
G
Google DoubleClick
G
Google Ads
L
LinkedIn

Technology detection powered by advanced web analysis

Powered byTechlist.ai